LEADER 04191nam  2201021z- 450 
001 9910367760103321
005 20231214132826.0
010   $a3-03921-452-7
035   $a(CKB)4100000010106116
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/61058
035   $a(EXLCZ)994100000010106116
100   $a20202102d2019      |y         0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aTowards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)
210   $cMDPI - Multidisciplinary Digital Publishing Institute$d2019
215   $a1 electronic resource (230 p.)
311   $a3-03921-451-9 
330   $aThis Special Issue of Cancers (Basel) is mainly dedicated to selecting papers from the talks given during the first Joint Meeting on Lung Cancer (JMLC) between the MD Anderson Cancer Center (Houston, Texas USA) and the Hospital University Federation (HUF) OncoAge (University Côte d?Azur, Nice, France) (Nice, September 2018). The central theme of JMLC is to discuss new advances and exchange ideas regarding lung cancer. Notably, the talks covered different topics on new therapeutic strategies (targeted therapy and immuno-oncology), molecular and cellular biology, biomarkers, and the epidemiology of lung cancer. Special attention was also given to lung cancer in elderly patients. The articles published in this Special Issue covered subjects such as the assessment of new biomarkers and new approaches for the early detection of lung cancer, epidemiological data, and emphasized a place for the newly characterized cellular pathways in lung cancer, which opens room for therapeutic perspectives for lung cancer patients.
517   $aTowards New Promising Discoveries for Lung Cancer Patients
610   $amicroRNAs
610   $amultiplexed
610   $ascreening
610   $aeducation
610   $anon-smoker
610   $aimage analysis
610   $aartificial intelligence
610   $aresearch
610   $alung cancer
610   $aspatial analysis
610   $aoptimization
610   $afluorescence
610   $ageriatric assessment
610   $ageriatric interventions
610   $aTNBC
610   $aliquid biopsy
610   $anon-small cell lung cancer
610   $aintegrated approaches
610   $awell-being
610   $ahormone-like action
610   $aEGFR mutations
610   $areversal of EMT
610   $atumor plasticity
610   $aimmune profiling
610   $amacrophage
610   $amultiplexed methodologies
610   $atargeted treatment
610   $atechniques
610   $aimmune-oncology
610   $abioinformatics
610   $aMALAT1
610   $along non-coding RNAs
610   $aCD8 T Cells
610   $apersonal medicine
610   $aEGFR TKIs
610   $alncRNA
610   $ahormones
610   $aelderly
610   $ainterleukin-1? and immunometabolism
610   $achromogenic
610   $axenograft
610   $ametastasis
610   $aPD-1/PD-L1 checkpoint blockade
610   $aimmunotherapy
610   $amolecular
610   $acancer tissues
610   $adigital
610   $aNSCLC
610   $aimmune blockade
610   $alung adenocarcinoma
610   $acirculating tumor cells
610   $abrightfield
610   $anon-coding RNAs
610   $aolder adults
610   $acancer
610   $atumor microenvironment
610   $aaging
610   $arational therapy
700   $aHofman$b Paul$4auth$01285355
702   $aCalin$b George$4auth
702   $aMani$b Sendurai$4auth
906   $aBOOK
912   $a9910367760103321
996   $aTowards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)$93019523
997   $aUNINA